Events Search and Views Navigation

Event Views Navigation

Filters

Changing any of the form inputs will cause the list of events to refresh with the filtered results.

Current

    • OnKure Therapeutics Virtual KOL Event to Discuss PI3Kα Inhibitor Medicines: Selectivity Matters & Pan-Mutant Allosteric Inhibition Delivers

    Join OnKure Therapeutics for a virtual key opinion leader (KOL) event featuring Benjamin F. Cravatt, PhD (The Scripps Research Institute)…
    TIME: 11:00 AM EDT
    LOCATION: Virtual
    View Details

    • Arrowhead Pharmaceuticals, Inc. 2026 Summer Series of R&D Webinars Part 1 – Cardiometabolic

    Join Arrowhead Pharmaceuticals for Part 1 of the 2026 Summer Series of R&D Webinars focusing on the Company's cardiometabolic pipeline,…
    TIME: 11:30 AM EDT
    LOCATION: Virtual
    View Details

    Transgene Virtual KOL Event: Expanding Transgene’s myvac® Platform into NSCLC with TG4070, an Individualized Neoantigen Therapeutic Vaccine

    Join Transgene for a virtual key opinion leader (KOL) event featuring Professor Nicolas Girard (MD, PhD, Professor of Thoracic Oncology at…
    TIME: 9:00 AM EDT
    LOCATION: Virtual
    View Details

    Hansa Biopharma Capital Markets Day

    Join Hansa Biopharma for a Capital Markets Day featuring key opinion leaders: Matthew Cooper, MD (Medical College of Wisconsin), Nassim Kamar,…
    TIME: 9:00 AM EDT
    LOCATION: St. Regis Hotel, New York & Live Webcast
    View Details

    Elicio Therapeutics Virtual KOL Event To Discuss Multiple Complete Responses After ELI-002 7P Treatment and Subsequent Therapy with Checkpoint Inhibition in Metastatic mKRAS Pancreatic Cancer

    Please join the Elicio Therapeutics management team for a virtual key opinion leader (KOL) event to discuss complete radiographic and…
    TIME: 1:00 PM EDT
    LOCATION: Virtual
    View Details

    TriSalus Life Sciences Virtual KOL Event Featuring New Real-World Evidence for Pressure-Enabled Drug Delivery™ in Liver Cancer

    Join TriSalus Life Sciences for a virtual key opinion leader (KOL) event that will feature the findings of a newly…
    TIME: 8:00 AM EDT
    LOCATION: Virtual
    View Details

    Ocular Therapeutix In-Person and Virtual Investor Day 2026 Featuring Retinal Disease KOLs

    Please join Ocular Therapeutix™ for its 2026 Investor Day featuring presentations from Ocular’s senior leadership and roundtable discussions with prominent…
    TIME: 2:00 PM EDT
    LOCATION: Midtown, New York and Live Webcast
    View Details

    Saniona Virtual R&D Day: SAN2668 (GABAA PAM) for the Treatment of Severe Pediatric Epilepsies

    Join Saniona for a virtual R&D Day featuring key opinion leader (KOL) Nicola Specchio, MD, PhD (Bambino Gesù Children's Hospital,…
    TIME: 10:00 AM EDT
    LOCATION: Virtual
    View Details

    Adocia S.A. – Advancing Mealtime Insulin Therapy: Phase 3 Results for BC Lispro in Type 2 Diabetes

    Join Adocia for a virtual key opinion leader (KOL) event featuring Tim Heise, MD (Profil, Neuss, Germany), who will join…
    TIME: 10:00 AM EDT
    LOCATION: Virtual
    View Details

    Humacyte, Inc. Virtual Investor Event to Discuss Positive V012 Phase 3 Results In Which ATEV Outperformed Standard of Care In Female Dialysis Access Patients

    Join Humacyte for a virtual investor event featuring KOL Mohamad A. Hussain, MD, PhD, RPVI, FAHA, FRCSC, FACS (Brigham &…
    TIME: 5:00 PM EDT
    LOCATION: Virtual
    View Details

    Lipocine Virtual KOL Event: Addressing Unmet Needs in Postpartum Depression (PPD) and the Clinical Potential of LPCN 1154

    Join Lipocine for a virtual KOL event focused on the continued unmet needs in postpartum depression (PPD) and the potential…
    TIME: 11:00 AM EDT
    LOCATION: Virtual
    View Details

    Nasus Pharma Virtual KOL Event to Discuss NS002 for the Treatment of Anaphylaxis

    Join Nasus Pharma for a virtual key opinion leader (KOL) event featuring Michael S. Blaiss, MD (Medical College of Georgia,…
    TIME: 8:00 AM EDT
    LOCATION: Virtual
    View Details

    Shattuck Labs Virtual Event to Discuss Phase 1 Clinical Data of SL-325, a Potentially First-in-Class DR3 Blocking Antibody, and Pipeline Update

    Join Shattuck Labs for a virtual event to discuss comprehensive Phase 1 clinical data of SL-325, a potentially first-in-class DR3…
    TIME: 8:00 AM EDT
    LOCATION: Virtual
    View Details

    Senseonics In-Person & Virtual Analyst Event to Discuss the Eversense 365 Platform for Type 1 and Type 2 Diabetes

    Join Senseonics for an in-person and virtual analyst event featuring KOL David T. Ahn, MD (Chief of Diabetes Services, Hoag),…
    TIME: 7:00 AM CDT
    LOCATION: 859 Convention Center Blvd, New Orleans, Louisiana, 70130
    View Details

    NextCure Virtual KOL Event to Discuss the ASCO 2026 Presentation of Dose Escalation Data from NXTC’s Phase 1 Trial of SIM0505 for the Treatment of Gynecologic Cancers including Ovarian Cancer and Uterine Serous Carcinoma

    Join NextCure for a virtual key opinion leader (KOL) event featuring Ursula Matulonis, MD (NextCure Scientific Advisory Board and Dana…
    TIME: 8:00 AM EDT
    LOCATION: Virtual
    View Details

    Corbus Pharmaceuticals – In-Person and Virtual Investor Event to Discuss Updated CRB–701 Monotherapy Data in HNSCC

    Join Corbus Pharmaceuticals for an in-person and virtual investor event featuring key opinion leaders (KOLs) Ari Rosenberg, MD (UChicago Medicine),…
    TIME: 6:30 AM CDT
    LOCATION: Marriott Marquis Chicago, 2121 S Prairie Ave, Chicago, IL 60616
    View Details